The same operation at one hospital can cost thousands more on another plan
Since 2021, hospitals must post the rates they negotiate with each insurer. The data confirms the same procedure at the same hospital varies widely by which insurer is paying.
The price of a hospital procedure is not one number. For the same operation, in the same building, a hospital can be paid strikingly different amounts depending on which insurer is footing the bill — and since 2021 there has been federal data to prove it. A rule requiring hospitals to publish the rates they negotiate with each insurer has, for the first time, let researchers see the spread directly, and the spread is large.
What the transparency rule actually did
Starting 1 January 2021, every hospital operating in the United States has been required to post clear pricing information online for the items and services it provides [s1]. In practice that means two things: a comprehensive machine-readable file listing the hospital's standard charges — including the specific rates it has negotiated with each insurance plan — and a more consumer-friendly display of prices for common "shoppable" services [s1]. Hospitals that fail to comply can face civil monetary penalties [s1].
The rule did not set or cap any prices. It is a disclosure rule: its entire theory is that publishing negotiated rates will let patients, employers and competitors see what everyone is paying, and that visibility will, over time, pull prices toward each other and downward. Whether it achieves that is still being studied. What it has already achieved is to make the previously secret negotiated rates visible — and the first thing that visibility revealed is how inconsistent they are.
How much the same procedure varies
A study published in the Journal of General Internal Medicine used this newly available data to examine a single, well-defined procedure — a hip or knee replacement, coded MS-DRG 470 — across 28 hospitals in the Chicago metropolitan area, comparing what two large insurers had negotiated at each [s2]. Using price-transparency data from February to September 2023, the researchers found a mean negotiated rate of $25,425 for the procedure [s2].
The variation around that average is the point. At the same hospital, the rates negotiated by Blue Cross Blue Shield of Illinois and by UnitedHealthcare differed by an average of $5,178 — about 20.4% of the mean negotiated rate [s2]. Across the hospitals studied, the price for this one operation ranged from $15,244, negotiated by Blue Cross at one hospital, to $38,328, negotiated by UnitedHealthcare at another — a spread of more than two and a half times for the same procedure [s2]. And there was no consistent pattern to who paid more: UnitedHealthcare had negotiated the higher rate at 17 of the 28 hospitals, and Blue Cross at 11 [s2]. Neither insurer was systematically the cheaper payer; the price simply depended on the particular deal struck at each hospital.
The study's authors are careful about its limits, describing it as exploratory: it covered one procedure in one metropolitan area, drawn from one commercial dataset, and did not systematically examine many procedures at once [s2]. It is a window, not a census. But the window is enough to establish the core fact — that for an identical, standardised operation, negotiated prices vary by thousands of dollars within the same hospital depending only on the insurer.
Why the variation exists at all
In a normal market, an identical product does not carry wildly different prices for different buyers of similar size. Hospital pricing works differently because each price is the outcome of a private negotiation between a hospital system and an insurer, shaped by their relative bargaining leverage in a local market rather than by the cost of the procedure. A hospital that dominates its region can command higher rates; an insurer with a large local membership can push them down. The procedure is the same; the leverage is not. That is why the transparency data shows scatter rather than a single going rate.
What the evidence supports, and what it does not
The claim that hospital prices for the same service vary substantially is now supported by direct evidence, not inference: the negotiated data shows differences of roughly a fifth of the price within a single hospital, and more than twofold across hospitals, for one standardised operation [s2]. What the evidence does not yet settle is whether the transparency rule is bending prices downward. The rule made the variation visible; demonstrating that visibility has narrowed it will take longer study across more procedures and years than any single dataset yet allows. For now, the durable finding is descriptive and important on its own terms: the price of an operation depends heavily on who is paying for it, and that was hidden until the data was pried open.
Sources
- Hospital Price Transparency — Centers for Medicare & Medicaid Services , January 1, 2021
- Understanding Variation in Negotiated Rates Using Novel Health Plan Price Transparency Data — Journal of General Internal Medicine , September 1, 2024
Three companies you've never chosen decide much of what your drugs cost
Pharmacy benefit managers sit between you, your insurer and the pharmacy. The three largest process nearly 80% of US prescriptions, and a federal regulator says the structure can raise costs.
Prior authorization delays care. A federal audit shows some denials are wrong.
Physician surveys report delays and abandoned treatment; those are self-reported. A harder number: a federal audit found 13% of Medicare Advantage denials met Medicare's own coverage rules.
A drug's 'price' is two different numbers, and the gap can be enormous
The list price is the sticker; the net price is what the maker keeps after rebates. For one insulin, list rose 27% over five years as the net price fell 10%. Who you are decides which you pay.
Medical debt is the largest US debt in collections. Erasing it changed little.
Americans owed about $140 billion in medical bills in collections. But two randomized experiments that relieved debt found no average effect on credit, financial distress or mental health.